참고문헌
- Abelson P, Kennedy D. The obesity epidemic. Science. 2004;304:1413. https://doi.org/10.1126/science.304.5676.1413
- Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Stateof-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension. 1999;33:537-541. https://doi.org/10.1161/01.HYP.33.1.537
- Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension. 2004;43:518-524. https://doi.org/10.1161/01.HYP.0000116223.97436.e5
- Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord. 2013;14:49-58. https://doi.org/10.1007/s11154-012-9230-8
- Uemura K, Mori N. Influence of age and sex on high-fat dietinduced increase in blood pressure. Nagoya J Med Sci. 2006;68:109-114.
- Davies MR, Gleich K, Katerelos M, Lee M, Mount PF, Power DA. The Thiazide-Sensitive Co-Transporter Promotes the Development of Sodium Retention in Mice with Diet-Induced Obesity. Kidney Blood Press Res. 2015;40:509-519. https://doi.org/10.1159/000368527
- Vargas-Robles H, Rios A, Arellano-Mendoza M, Escalante BA, Schnoor M. Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice. Oxid Med Cell Longev. 2015;2015:467471.
- Boustany-Kari CM, Gong M, Akers WS, Guo Z, Cassis LA. Enhanced vascular contractility and diminished coronary artery flow in rats made hypertensive from diet-induced obesity. Int J Obes (Lond). 2007;31:1652-1659. https://doi.org/10.1038/sj.ijo.0803426
- Wang Y, Song Y, Suo M, Jin X, Tian G. Telmisartan prevents highfat diet-induced hypertension and decreases perirenal fat in rats. J Biomed Res. 2012;26:219-225.
- Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, Orsy P, Horvath B, Maser-Gluth C, Greiner E, Lemmer B, Schutz G, Gutkind JS, Offermanns S. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med. 2008;14:64-68. https://doi.org/10.1038/nm1666
- Brooks DP, Ruffolo RR Jr. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure. J Hypertens Suppl. 1999;17:S27-32. https://doi.org/10.1097/00004872-199917010-00005
- Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesityinduced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991-1006. https://doi.org/10.1161/CIRCRESAHA.116.305697
- Kadakol A, Malek V, Goru SK, Pandey A, Bagal S, Gaikwad AB. Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochem Biophys Res Commun. 2015;461:342-347. https://doi.org/10.1016/j.bbrc.2015.04.036
- Zhang X, Yan SM, Zheng HL, Hu DH, Zhang YT, Guan QH, Ding QL. A mechanism underlying hypertensive occurrence in the metabolic syndrome: cooperative effect of oxidative stress and calcium accumulation in vascular smooth muscle cells. Horm Metab Res. 2014;46:126-132.
- Savineau JP, Marthan R. Modulation of the calcium sensitivity of the smooth muscle contractile apparatus: molecular mechanisms, pharmacological and pathophysiological implications. Fundam Clin Pharmacol. 1997;11:289-299. https://doi.org/10.1111/j.1472-8206.1997.tb00841.x
-
Somlyo AP, Somlyo AV.
$Ca^{2+}$ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83:1325-1358. https://doi.org/10.1152/physrev.00023.2003 - Margolis M, Perez O Jr, Martinez M, Santander AM, Mendez AJ, Nadji M, Nayer A, Bhattacharya S, Torroella-Kouri M. Phospholipid makeup of the breast adipose tissue is impacted by obesity and mammary cancer in the mouse: Results of a pilot study. Biochimie. 2015;108:133-139. https://doi.org/10.1016/j.biochi.2014.11.009
- Kim JI, Jung SW, Yang E, Park KM, Eto M, Kim IK. Heat shock augments angiotensin II-induced vascular contraction through increased production of reactive oxygen species. Biochem Biophys Res Commun. 2010;399:452-457. https://doi.org/10.1016/j.bbrc.2010.07.115
- Bray GA. Risks of obesity. Endocrinol Metab Clin North Am. 2003;32:787-804. https://doi.org/10.1016/S0889-8529(03)00067-7
- Soltani Z, Washco V, Morse S, Reisin E. The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches. Curr Hypertens Rep. 2015;17:7. https://doi.org/10.1007/s11906-014-0520-2
- Dharmarajan TS, Dharmarajan L. Tolerability of Antihypertensive Medications in Older Adults. Drugs Aging. 2015;32:773-796. https://doi.org/10.1007/s40266-015-0296-3
- Abraham HM, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015; 38:33-54. https://doi.org/10.1007/s40264-014-0239-7
- Curb JD, Schneider K, Taylor JO, Maxwell M, Shulman N. Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program. Hypertension. 1988;11:II51-55.
- Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001;15:2727-2729. https://doi.org/10.1096/fj.01-0457fje
- Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, Ward R, Forrester T. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens. 1997;11:107-111. https://doi.org/10.1038/sj.jhh.1000391
- Li H, Li M, Liu P, Wang Y, Zhang H, Li H, Yang S, Song Y, Yin Y, Gao L, Cheng S, Cai J, Tian G. Telmisartan ameliorates nephropathy in metabolic syndrome by reducing leptin release from perirenal adipose tissue. Hypertension. 2016;68:478-490. https://doi.org/10.1161/HYPERTENSIONAHA.116.07008
- Maneesai P, Bunbupha S, Kukongviriyapan U, Prachaney P, Tangsucharit P, Kukongviriyapan V, Pakdeechote P. Asiatic acid attenuates renin-angiotensin system activation and improves vascular function in high-carbohydrate, high-fat diet fed rats. BMC Complement Altern Med. 2016;16:123. https://doi.org/10.1186/s12906-016-1100-6
- Yiannikouris F, Wang Y, Shoemaker R, Larian N, Thompson J, English VL, Charnigo R, Su W, Gong M, Cassis LA. Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice. Hypertension. 2015;66:836-842. https://doi.org/10.1161/HYPERTENSIONAHA.115.06040
-
Kosaka S, Pelisch N, Rahman M, Nakano D, Hitomi H, Kobori H, Fukuoka N, Kobara H, Mori H, Masaki T, Cervenka L, Matsumura Y, Houchi H, Nishiyama A. Effects of angiotensin II
$AT_1$ -receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats. J Pharmacol Sci. 2013;121:95-102. https://doi.org/10.1254/jphs.12169FP - Viswanad B, Srinivasan K, Kaul CL, Ramarao P. Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res . 2006;53:209-215. https://doi.org/10.1016/j.phrs.2005.11.002
- Wynne BM, Chiao CW, Webb RC. Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1. J Am Soc Hypertens. 2009;3:84-95. https://doi.org/10.1016/j.jash.2008.09.002
- Walsh MP, Susnjar M, Deng J, Sutherland C, Kiss E, Wilson DP. Phosphorylation of the protein phosphatase type 1 inhibitor protein CPI-17 by protein kinase C. Methods Mol Biol. 2007;365:209-223.
- Kobayashi T, Matsumoto T, Kamata K. The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models. J Smooth Muscle Res. 2005;41:283-302. https://doi.org/10.1540/jsmr.41.283
피인용 문헌
- Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis vol.41, pp.11, 2017, https://doi.org/10.1038/ijo.2017.166
- The essential role of phospho‐T38 CPI‐17 in the maintenance of physiological blood pressure using genetically modified mice vol.32, pp.4, 2018, https://doi.org/10.1096/fj.201700794r
- Cardiac Autonomic Neuropathy as a Result of Mild Hypercaloric Challenge in Absence of Signs of Diabetes: Modulation by Antidiabetic Drugs vol.2018, pp.None, 2017, https://doi.org/10.1155/2018/9389784
- Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production vol.393, pp.3, 2017, https://doi.org/10.1007/s00210-019-01749-5
- Hypoxic modulation of fetal vascular MLCK abundance, localization, and function vol.320, pp.1, 2017, https://doi.org/10.1152/ajpregu.00212.2020
- Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension vol.11, pp.7, 2017, https://doi.org/10.3390/life11070702
- Inhibition of HDACs (Histone Deacetylases) Ameliorates High-Fat Diet-Induced Hypertension Through Restoration of the MsrA (Methionine Sulfoxide Reductase A)/Hydrogen Sulfide Axis vol.78, pp.4, 2021, https://doi.org/10.1161/hypertensionaha.121.17149